Carregant...
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening
BACKGROUND: Prostate-specific antigen (PSA) has modest specificity for prostate cancer. A panel of four kallikrein markers (total, free, and intact PSA and kallikrein-related peptidase 2) is a highly accurate predictor of biopsy outcome. The clinical significance of biopsy-detectable cancers in men...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3035761/ https://ncbi.nlm.nih.gov/pubmed/21148123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-10-1003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|